Bifidobacterium longum subsp. infantis CCFM1426 enhances the anti-colitic effect of vitamin A via retinoic acid restoration and gut microbiota modulation in ulcerative colitis mice
Frontiers in Nutrition · 24.07.2025 · 12
DOI: 10.3389/fnut.2025.1644649 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Nutrition, online erschienen am 24.07.2025. Verfasst von Xihua Yu und 6 weiteren Autor:innen. Beteiligte Einrichtung: Sinopharm Xingsha Pharmaceutical (Xiamen) Co., Ltd., Xiamen, Fujian, China. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Ulcerative colitis (UC) is a chronic inflammatory bowel disease with increasing global prevalence, making it a significant health concern. Although vitamin A (VA) plays a beneficial role in UC management, its therapeutic efficacy is limited by impaired absorption and disrupted retinoic acid (RA) metabolism. Gut microbiota are known to influence VA metabolic pathways, offering potential targets to enhance VA bioavailability and efficacy.
Methods
A dextran sulphate sodium (DSS)-induced mouse model of colitis was established to evaluate the therapeutic effects of co-administering Bifidobacterium longum subsp. infantis CCFM1426 with vitamin A. Body weight, disease activity index (DAI) and colon length were monitored in mice with DSS-induced colitis. Serum levels of intestinal injury markers, inflammatory cytokines, antioxidant enzymes and colonic RA levels were measured using ELISA kits. Metagenomic analysis investigated gut microbiota composition.
Results
It was indicated that the VA and CCFM1426 combination significantly improved colon length and DAI, enhanced serum levels of intestinal injury markers (lipopolysaccharide-binding protein, intestinal fatty acid-binding protein, diamine oxidase) and cytokines (IL-6, TNF- α , IL-10), and restored antioxidant capacity. The combination demonstrated superior efficacy in colonic RA levels and contributed to gut microbiota diversity restoration. Metabolomics analysis showed that colitis mice treated with the combination had higher levels of eicosapentaenoic acid, adenosine and anandamide.
Conclusion
These findings provide novel evidence that co-administration of CCFM1426 and VA synergistically alleviates colitis by enhancing RA bioavailability through microbiota-dependent pathways.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Sinopharm Xingsha Pharmaceutical (Xiamen) Co., Ltd., Xiamen, Fujian, China.
- Xiamen Key Laboratory of Maternal and Infant Health and Nutrition Products, Xiamen, Fujian, China.
- State Key Laboratory of Food Science and Resources, Jiangnan University, Wuxi, Jiangsu, China.
- School of Food Science and Technology, Jiangnan University, Wuxi, Jiangsu, China.
- Department of Nephrology, The Affiliated Wuxi People's Hospital of Nanjing Medical University, Wuxi People's Hospital, Wuxi Medical Center, Nanjing Medical University, Wuxi, Jiangsu, China.
Zitieren
APA
Yu, X., Huang, L., Wang, Y., Li, L., Lu, W., Zhang, Z., & Wang, H. (2025). Bifidobacterium longum subsp. infantis CCFM1426 enhances the anti-colitic effect of vitamin A via retinoic acid restoration and gut microbiota modulation in ulcerative colitis mice. Frontiers in Nutrition, 12. https://doi.org/10.3389/fnut.2025.1644649
Vancouver
Yu X, Huang L, Wang Y, Li L, Lu W, Zhang Z, et al. Bifidobacterium longum subsp. infantis CCFM1426 enhances the anti-colitic effect of vitamin A via retinoic acid restoration and gut microbiota modulation in ulcerative colitis mice. Frontiers in Nutrition. 2025;12. doi:10.3389/fnut.2025.1644649
BibTeX
@article{Yu2025,
author = {Yu, Xihua and Huang, Liming and Wang, Yi and Li, Liuruolan and Lu, Wenwei and Zhang, Zhijian and Wang, Hongchao},
title = {Bifidobacterium longum subsp. infantis CCFM1426 enhances the anti-colitic effect of vitamin A via retinoic acid restoration and gut microbiota modulation in ulcerative colitis mice},
journal = {Frontiers in Nutrition},
year = {2025},
volume = {12},
doi = {10.3389/fnut.2025.1644649}
}
EUVIMED